WELLINGTON MANAGEMENT GROUP LLP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 902219 Boston, MA

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,434,549,489

-$298,070,473 QoQ

Shares Held

3,212,589

-15.9% QoQ

Ownership

1.27%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 96.84836746935261.ToString("F0")% None 3.1516325306473996.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,771 across 180 Biotechnology names. VRTX ranks #1 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,434,549,489	3,212,589	-15.9%	Shares	Defined	2026-05-15
2025-12-31	$1,732,619,962	3,821,731	-19.9%	Shares	Defined	2026-02-17
2025-09-30	$1,868,922,524	4,772,042	-0.9%	Shares	Defined	2025-11-14
2025-06-30	$2,142,919,444	4,813,386	-11.8%	Shares	Defined	2025-08-14
2025-03-31	$2,644,570,922	5,454,748	-7.8%	Shares	Defined	2025-05-13
2024-12-31	$2,382,407,022	5,916,084	+23.3%	Shares	Defined	2025-02-12
2024-09-30	$2,231,858,455	4,798,870	+17.2%	Shares	Defined	2024-11-14
2024-06-30	$1,919,150,132	4,094,449	-10.2%	Shares	Defined	2024-08-14
2024-03-31	$1,905,386,973	4,558,233	-12.8%	Shares	Defined	2024-05-15
2023-12-31	$2,127,439,822	5,228,538	-19.9%	Shares	Defined	2024-02-12
2023-09-30	$2,269,299,422	6,525,851	-13.6%	Shares	Defined	2023-11-14
2023-06-30	$2,657,938,923	7,552,894	+0.5%	Shares	Defined	2023-08-14
2023-03-31	$2,368,553,842	7,517,548	+10.1%	Shares	Defined	2023-05-12
2022-12-31	$1,971,669,413	6,827,583	-15.0%	Shares	Defined	2023-02-13
2022-09-30	$2,324,815,679	8,029,342	-2.5%	Shares	Defined	2022-11-14
2022-06-30	$2,320,720,709	8,235,639	+2.3%	Shares	Defined	2022-08-15
2022-03-31	$2,101,776,695	8,053,710	+23.6%	Shares	Defined	2022-05-16
2021-12-31	$1,431,452,713	6,518,455	+7.0%	Shares	Defined	2022-02-11
2021-09-30	$1,104,862,629	6,091,089	-26.6%	Shares	Defined	2021-11-15
2021-06-30	$1,672,659,769	8,295,689	+2.6%	Shares	Defined	2021-08-16
2021-03-31	$1,737,678,756	8,086,364	-12.2%	Shares	Defined	2021-05-17
2020-12-31	$2,175,866,804	9,206,511	+48.8%	Shares	Defined	2021-02-12
2020-09-30	$1,683,460,579	6,186,464	-4.3%	Shares	Defined	2020-11-16
2020-06-30	$1,875,928,056	6,461,810	-15.1%	Shares	Defined	2020-08-14
2020-03-31	$1,811,220,191	7,611,768	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.